For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Abelson leukemia virus-induced pre-B tumor cells (Mouse)
This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5,268,486 and related patents. Cy and CyDye are trademarks of GE Healthcare Limited.
In vivo administration of ab25525 has been shown to affect differentiation of both T and B cells in normal mice and reduce the level of anti-DNA antibodies and lymphadenopathies in MRL/lpr mice.
Our Abpromise guarantee covers the use of ab25525 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|Flow Cyt||Use at an assay dependent concentration.|
|IHC-Fr||Use at an assay dependent concentration.|
|IP||Use at an assay dependent concentration.|
C57Bl/6 splenocytes stained with 0.125µg ab25525 (solid line) or 0.125µg PE-Cy5-conjugated rat IgG2a isotype control (dashed line).